KRTAP20-3
gene geneOn this page
Also known as KAP20.3KAP19D
Summary
KRTAP20-3 (keratin associated protein 20-3, HGNC:34001) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 20-3 (Q3LI60). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in intermediate filament.
Source: NCBI Gene 337985 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001128077
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34001 |
| Approved symbol | KRTAP20-3 |
| Name | keratin associated protein 20-3 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP20.3, KAP19D |
| Ensembl gene | ENSG00000206104 |
| Ensembl biotype | protein_coding |
| Entrez | 337985 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382826
RefSeq mRNA: 1 — MANE Select: NM_001128077
NM_001128077
CCDS: CCDS46642
Canonical transcript exons
ENST00000382826 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001493466 | 30642864 | 30643136 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 91.48.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.48 | gold quality |
| granulocyte | CL:0000094 | 56.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 40.03 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.36 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| monocyte | CL:0000576 | 25.96 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 24.88 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 23.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting KRTAP20-3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4697-3P | 99.89 | 67.09 | 1123 |
| HSA-MIR-1279 | 97.83 | 67.50 | 1898 |
| HSA-MIR-1271-3P | 97.56 | 64.85 | 865 |
| HSA-MIR-550A-3-5P | 97.56 | 65.35 | 823 |
| HSA-MIR-550A-5P | 97.56 | 65.35 | 823 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
| HSA-MIR-711 | 96.60 | 65.75 | 528 |
| HSA-MIR-4280 | 96.44 | 67.69 | 473 |
| HSA-MIR-3935 | 96.33 | 66.79 | 797 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 20-3 — Q3LI60 (reviewed: Q3LI60)
All UniProt accessions (1): Q3LI60
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 20 family.
RefSeq proteins (1): NP_001121549* (*=MANE)
Domains & families (InterPro)
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI60-F1 | 41.33 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, MIR3935, MIR550A_3_5P_MIR550A_5P, MIR1271_3P, MIR711
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): intermediate filament (GO:0005882)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
24 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP20-3 | PURG | Q9UJV8 | 697 |
| KRTAP20-3 | GAGE2A | Q6NT46 | 591 |
| KRTAP20-3 | CFAP251 | Q8TBY9 | 570 |
| KRTAP20-3 | B3GNT7 | Q8NFL0 | 541 |
| KRTAP20-3 | ADAMTS6 | Q9UKP5 | 474 |
| KRTAP20-3 | TM4SF1 | P30408 | 417 |
| KRTAP20-3 | KRT17 | Q04695 | 307 |
| KRTAP20-3 | KRTAP22-1 | Q3MIV0 | 0 |
| KRTAP20-3 | KRTAP19-7 | Q3SYF9 | 0 |
| KRTAP20-3 | KRTAP20-1 | Q3LI63 | 0 |
| KRTAP20-3 | KRTAP23-1 | A1A580 | 0 |
| KRTAP20-3 | KRTAP22-2 | Q3LI68 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI60, Q3LI72, O08632, Q3LHN2, Q3LI70, Q3LI73, Q3SYF9, Q7Z4W3, Q8IUB9, Q925H2, Q925H7, Q925I0, Q99NG9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
113 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30642894:C:G | donor_gain | 0.8000 |
| 21:30642917:GAC:G | donor_gain | 0.7100 |
| 21:30642934:GACT:G | donor_gain | 0.7100 |
| 21:30642923:GC:G | donor_gain | 0.6600 |
| 21:30642938:G:GG | donor_gain | 0.6500 |
| 21:30642924:C:G | donor_gain | 0.6200 |
| 21:30642922:GGC:G | donor_gain | 0.6100 |
| 21:30642935:ACT:A | donor_gain | 0.5900 |
| 21:30642929:GC:G | donor_gain | 0.5700 |
| 21:30642930:C:G | donor_gain | 0.5700 |
| 21:30642914:G:GT | donor_gain | 0.5600 |
| 21:30643007:GTGGG:G | donor_gain | 0.4800 |
| 21:30642903:C:T | donor_gain | 0.4600 |
| 21:30642942:A:G | donor_gain | 0.4500 |
| 21:30642996:A:G | donor_gain | 0.4500 |
| 21:30642889:A:AG | donor_gain | 0.4400 |
| 21:30642936:CT:C | donor_gain | 0.4400 |
| 21:30642950:A:AG | donor_gain | 0.4400 |
| 21:30643011:G:GT | donor_gain | 0.4400 |
| 21:30642913:G:GT | donor_gain | 0.4100 |
| 21:30642948:T:G | donor_gain | 0.3900 |
| 21:30642889:A:G | donor_gain | 0.3400 |
| 21:30642937:T:G | donor_gain | 0.3400 |
| 21:30643008:TG:T | donor_gain | 0.3400 |
| 21:30643009:GG:G | donor_gain | 0.3400 |
| 21:30643010:GG:G | donor_gain | 0.3400 |
| 21:30643066:C:T | donor_gain | 0.3400 |
| 21:30643112:AGG:A | acceptor_gain | 0.3300 |
| 21:30643113:GGG:G | acceptor_gain | 0.3300 |
| 21:30642866:C:T | donor_gain | 0.3200 |
AlphaMissense
276 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30642970:T:C | F28L | 0.979 |
| 21:30642972:T:A | F28L | 0.979 |
| 21:30642972:T:G | F28L | 0.979 |
| 21:30642961:T:C | F25L | 0.955 |
| 21:30642963:T:A | F25L | 0.955 |
| 21:30642963:T:G | F25L | 0.955 |
| 21:30642939:T:G | C17W | 0.954 |
| 21:30642997:T:C | C37R | 0.928 |
| 21:30642937:T:C | C17R | 0.925 |
| 21:30642937:T:A | C17S | 0.921 |
| 21:30642938:G:C | C17S | 0.921 |
| 21:30642997:T:A | C37S | 0.921 |
| 21:30642998:G:C | C37S | 0.921 |
| 21:30642987:T:G | C33W | 0.908 |
| 21:30642971:T:C | F28S | 0.907 |
| 21:30642999:T:G | C37W | 0.907 |
| 21:30642938:G:A | C17Y | 0.877 |
| 21:30642975:A:C | R29S | 0.861 |
| 21:30642975:A:T | R29S | 0.861 |
| 21:30643003:T:C | C39R | 0.857 |
| 21:30642985:T:C | C33R | 0.854 |
| 21:30642970:T:A | F28I | 0.847 |
| 21:30642938:G:T | C17F | 0.846 |
| 21:30642971:T:G | F28C | 0.837 |
| 21:30642965:G:A | G26D | 0.825 |
| 21:30643005:T:G | C39W | 0.820 |
| 21:30643003:T:A | C39S | 0.805 |
| 21:30643004:G:C | C39S | 0.805 |
| 21:30642985:T:A | C33S | 0.801 |
| 21:30642986:G:C | C33S | 0.801 |
dbSNP variants (sampled 300 via entrez): RS1000794565 (21:30641249 T>G), RS1001076881 (21:30641658 G>A), RS1001796272 (21:30642807 G>A), RS1002378632 (21:30642458 G>A), RS1005789108 (21:30643595 A>G), RS1006137672 (21:30641968 C>T), RS1007307134 (21:30641465 T>C), RS1008310872 (21:30641683 C>A,G), RS1009207062 (21:30642228 G>T), RS1009215218 (21:30643406 G>A), RS1009266208 (21:30643185 C>A,T), RS1010181652 (21:30641168 G>A), RS1012500003 (21:30641229 C>T), RS1012913155 (21:30640983 G>T), RS1013511998 (21:30642325 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| pentanal | increases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.